Brief: Sutro Biopharma Achieves 'First In Human' Milestone In Cytokine Derivatives Collaboration With Merck
26/07/2022 23:00
July 26 (Reuters) - Sutro Biopharma Inc:
* SUTRO BIOPHARMA ACHIEVES "FIRST IN HUMAN" MILESTONE IN
CYTOKINE
DERIVATIVES COLLABORATION WITH MERCK
Source text for Eikon: ID:nGNXc6wDdR
Further company coverage: MRK.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates